In silico evaluation and feasibility of near margin-less head and neck daily adaptive radiotherapy

Personalized medicine is transforming the landscape of treatment options throughout oncology. Targeted systemic agents and immunotherapies have shown great success in optimizing patient outcomes, while liquid biopsies are trying to unravel the intricacies of tailored cancer management [1]. The field of radiation oncology is also embracing efforts to personalize treatments through real-time treatment planning and biomarker-guided dose adjustments [2,3,4,5].

Source: Radiotherapy and Oncology - March 5, 2024 Category: Radiology Authors: Michael Dohopolski, Justin Visak, Byongsu Choi, Boyu Meng, David Parsons, Xinran Zhong, Enobong Inam, Vlad Avkshtol, Dominic Moon, David Sher, Mu-Han Lin Tags: Original Article Source Type: research